脑癌诊断市场规模预计将从 2022 年的 16.391 亿美元增至 2028 年的 73.7857 亿美元;预计 2022 年至 2028 年的复合年增长率为 28.5%。CAGR of 28.5% from 2022 to 2028.
脑癌是由脑内细胞向外生长而引起的,从而导致肿瘤。脑肿瘤包括原发性脑肿瘤和继发性脑肿瘤。原发性脑肿瘤在脑内形成,不会扩散到身体其他部位,而继发性肿瘤,也称为转移性肿瘤,是那些始于身体其他部位的癌症。脑肿瘤分为 40 种主要类型,进一步分为两大类,包括良性肿瘤(即生长缓慢且扩散可能性较小)和恶性肿瘤(即癌性肿瘤,扩散可能性较大)。
脑癌诊断市场细分为诊断类型、癌症类型、最终用户、肿瘤大小和地域。按地域划分,市场大致分为北美、欧洲、亚太地区、中东和非洲以及南美和中美。该报告提供了对市场的深入见解,强调了市场趋势、技术进步和市场动态等参数,并分析了主要市场参与者的竞争格局。
定制此报告以满足您的需求
您可以免费定制任何报告,包括本报告的部分内容、国家级分析、Excel 数据包,以及为初创企业和大学提供优惠和折扣
- 获取此报告的关键市场趋势。这个免费样品将包括数据分析,从市场趋势到估计和预测。
市场洞察
脑肿瘤发病率上升显著促进市场增长
根据美国临床肿瘤学会 (ASCO) 的数据,2021 年,美国约有 24,530 名成年人(13,840 名男性和 10,690 名女性)被诊断出患有原发性脑和脊髓癌性肿瘤。在人的一生中,患上这种肿瘤的几率不到 1%。大多数原发性中枢神经系统 (CNS)恶性肿瘤都是脑肿瘤,占所有病例的 85% 至 90%。脑肿瘤可能是致命的,严重影响生活质量,并最终改变患者及其家人的生活。
同样,英国癌症研究中心估计,英国每年约有 12,288 例新诊断的脑肿瘤、其他中枢神经系统肿瘤和颅内肿瘤病例,即每天约有 34 例(2016-2018 年)。脑肿瘤、其他中枢神经系统肿瘤和颅内肿瘤是英国第九大常见恶性肿瘤,占所有新癌症病例的 3%(2016-2018 年)。此外,它是英国女性中第七大常见癌症,2016-2018 年期间约有 6,400 例新病例。同样,在男性中,脑肿瘤、其他中枢神经系统肿瘤和颅内肿瘤是第 11 大常见癌症,2016-2018 年期间英国约有 5,800 例新病例。在英国,85 至 89 岁人群(2016-2018 年)的脑肿瘤发病率最高。
根据美国神经外科医师协会的数据,胶质母细胞瘤是最常见的恶性脑肿瘤和其他中枢神经系统肿瘤,占所有病例的 47.7%;胶质母细胞瘤的发病率为每 10 万人 3.21 例。根据澳大利亚癌症协会的数据,2020 年澳大利亚诊断出约 1,879 例新的脑癌病例。
早期发现肿瘤往往能提供更多治疗选择。先进的成像技术可以精确定位脑肿瘤的位置。术中MRI还可以指导手术中的组织活检和肿瘤切除。磁共振波谱(MRS)用于检查肿瘤的化学特性。因此,全球脑癌发病率的增加对脑癌诊断工具的需求很高。
基于诊断类型的见解
根据诊断类型,脑癌诊断市场细分为影像测试、腰椎穿刺、活检、分子检测、平台和服务、脑动脉造影、神经和听力测试/神经认知评估、脑电图 (EEG)等。此外,影像测试部分细分为 MRI、CT 扫描、PET 等。同样,平台和服务部分细分为样品载玻片、自动采样器单元、解决方案和平台以及服务。2022 年,影像测试部分可能会占据最大的市场份额。然而,预计平台和服务部分将在 2022 年至 2028 年的预测期内在脑癌诊断市场中实现最高复合年增长率。
基于癌症类型的见解
根据癌症类型,全球脑癌诊断市场细分为听神经瘤、星形细胞瘤、颅咽管瘤、神经节瘤、多形性胶质母细胞瘤、脑膜瘤、室管膜瘤、少突胶质细胞瘤、低度肿瘤和其他脑癌类型。2022 年,多形性胶质母细胞瘤细分市场可能占据最大的市场份额。此外,由于全球多形性胶质母细胞瘤发病率上升,预计同一细分市场的需求将在 2022 年至 2028 年期间以最快的复合年增长率增长。
基于肿瘤大小的见解
根据肿瘤大小,全球脑癌诊断市场分为 0.2 cm3 至 100 cm3、101 cm3 至 200 cm3 和 200 cm3 以上。2022 年,0.2 cm3 至 100 cm3 细分市场可能占据最大的市场份额。此外,由于全球各种医疗状况的检测和诊断增加,预计 2022 年至 2028 年期间 0.2 cm3 至 100 cm3 细分市场的需求将以最快的复合年增长率增长。
基于最终用户的洞察
根据最终用户,脑癌诊断市场细分为医院、专科诊所、门诊手术中心、诊断中心和研究机构等。2022 年,医院部门可能会占据最大的市场份额。此外,由于全球医院采用先进的脑癌诊断技术,预计专科诊所部门的需求将在 2022 年至 2028 年期间以 29.4% 的复合年增长率增长。
产品发布、并购是全球脑癌诊断市场参与者广泛采用的策略。以下列出了一些近期的关键市场发展:
2021 年 9 月,OPKO Health 旗下公司 BioReference Laboratories, Inc. 及其专业肿瘤学部门 GenPath 宣布推出 OnkoSight AdvancedTM,这是一款下一代测序 (NGS) 检测试剂,可对肿瘤样本进行革命性的脱氧核糖核酸 (DNA) 突变分析。
基于地理位置的洞察
按地域划分,全球脑癌诊断市场大致分为北美(美国、加拿大和墨西哥)、欧洲(法国、德国、英国、西班牙、意大利和欧洲其他地区)、亚太地区(中国、印度、日本、澳大利亚、韩国和亚太地区其他地区)、中东和非洲(沙特阿拉伯、阿联酋、南非和中东和非洲其他地区)以及南美洲和中美洲(巴西、阿根廷和南美洲和中美洲其他地区)。
脑癌诊断市场区域洞察
Insight Partners 的分析师已详尽解释了预测期内影响脑癌诊断市场的区域趋势和因素。本节还讨论了北美、欧洲、亚太地区、中东和非洲以及南美和中美洲的脑癌诊断市场细分和地理位置。
- 获取脑癌诊断市场的区域特定数据
脑癌诊断市场报告范围
报告属性 | 细节 |
---|---|
2022 年市场规模 | 16.4亿美元 |
2028 年市场规模 | 73.8亿美元 |
全球复合年增长率(2022 - 2028) | 28.5% |
史料 | 2020-2021 |
预测期 | 2023-2028 |
涵盖的领域 | 按诊断类型
|
覆盖地区和国家 | 北美
|
市场领导者和主要公司简介 |
|
市场参与者密度:了解其对商业动态的影响
脑癌诊断市场正在快速增长,这得益于终端用户需求的不断增长,而这些需求又源于消费者偏好的不断变化、技术进步以及对产品优势的认识不断提高等因素。随着需求的增加,企业正在扩大其产品范围,进行创新以满足消费者的需求,并利用新兴趋势,从而进一步推动市场增长。
市场参与者密度是指在特定市场或行业内运营的企业或公司的分布情况。它表明在给定市场空间中,相对于其规模或总市场价值,有多少竞争对手(市场参与者)存在。
在脑癌诊断市场运营的主要公司有:
- 赛默飞世尔科技公司
- 西门子医疗股份公司
- 通用电气医疗
- MDxHealth
- 南特组学公司
免责声明:上面列出的公司没有按照任何特定顺序排列。
- 了解脑癌诊断市场顶级关键参与者概况
基于公司的见解
赛默飞世尔科技公司、西门子医疗股份公司、通用电气医疗集团、MDxHealth、NantOmics、Biocept 公司、荷兰皇家飞利浦电子公司、佳能医疗系统、日立公司、东软医疗系统、KITZ HEIDELBERG、GENPATH、NVIDIA 公司、ONCORA MEDICAL、BIOMIND、SOPHIA AND ONCODNA、Clinspec Diagnostics、Raindance Technologies 公司、罗氏诊断公司和 Illumina 公司是脑癌诊断市场的领先公司
- Historical Analysis (2 Years), Base Year, Forecast (7 Years) with CAGR
- PEST and SWOT Analysis
- Market Size Value / Volume - Global, Regional, Country
- Industry and Competitive Landscape
- Excel Dataset
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
Koninklijke Philips N.V. and GE Healthcare are the top two companies that hold huge market shares in the brain cancer diagnostics market.
Brain cancers are caused due to extracellular growth of the cells in the brain that causes tumors. The tumor includes primary brain tumors and secondary brain tumors. Primary brain tumors are formed in the brain and do not spread to other body parts, whereas secondary tumors, also known as metastases, are those cancers that began in another part of the body. Brain tumors are categorized into 40 major types that are further classified into two major groups, including benign, i.e., slow-growing and have less possibility to spread, and malignant, i.e., cancerous, and more likely to spread.
Key factors driving the growth of this market are the increase in brain cancer worldwide and the rise in cigarette smokers expected to drive the market during the forecast period.
In 2021, the glioblastoma multiforme segment accounted for the largest share of the market; it is further expected to continue its dominance over the forecast period. The major driving factor for the growth of the glioblastoma multiforme segment is the growing incidence of glioblastoma multiforme. Moreover, the increasing awareness about brain cancer diagnostics among the population is one of the significant factors in the growth of the glioblastoma multiforme segment.
In 2021, the imaging test held the largest share of the market by drug development type. It is expected to report a higher CAGR of 29.5% during 2021–2028.
The CAGR value of the brain cancer diagnostics market during the forecasted period of 2021–2028 is 28.5%.
The brain cancer diagnostics market majorly consists of players such as THERMO FISHER SCIENTIFIC INC, Siemens Healthineers AG, GE Healthcare, MDxHealth, NantOmics, Biocept, Inc., Koninklijke Philips N.V., Canon Medical Systems, Hitachi, Ltd., Neusoft Medical Systems, KITZ HEIDELBERG, GENPATH, NVIDIA CORPORATION, ONCORA MEDICAL, BIOMIND, SOPHIA AND ONCODNA, Clinspec Diagnostics, Raindance Technologies, Inc, ROCHE DIAGNOSTICS, Illumina, Inc.
Trends and growth analysis reports related to Life Sciences : READ MORE..
The List of Companies - Brain Cancer Diagnostics Market
- THERMO FISHER SCIENTIFIC INC
- Siemens Healthineers AG
- GE Healthcare
- MDxHealth
- NantOmics
- Biocept, Inc.
- Koninklijke Philips N.V.
- Canon Medical Systems
- Hitachi, Ltd
- Neusoft Medical Systems
- KITZ HEIDELBERG
- GENPATH
- NVIDIA CORPORATION
- ONCORA MEDICAL
- BIOMIND
- SOPHIA AND ONCODNA
- Clinspec Diagnostics
- Raindance Technologies, Inc
- ROCHE DIAGNOSTICS
- Illumina, Inc.
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.